MedPath
HSA Approval

MITOXANTRONE BAXTER INJECTION 2 mg/ml

SIN11629P

MITOXANTRONE BAXTER INJECTION 2 mg/ml

MITOXANTRONE BAXTER INJECTION 2 mg/ml

August 15, 2001

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

L01DB07

mitoxantrone

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER ONCOLOGY GMBH

Active Ingredients

MITOXANTRONE HCl EQV MITOXANTRONE

2 mg/ml

Mitoxantrone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MITOXANTRONE BAXTER INJECTION 2 mg/ml - HSA Approval | MedPath